van Rij RP - Search Results

1

Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.

van Rij RP, Hazenberg MD, van Benthem BH, Otto SA, Prins M, Miedema F, Schuitemaker H. van Rij RP, et al. Among authors: van benthem bh. AIDS Res Hum Retroviruses. 2003 May;19(5):389-98. doi: 10.1089/088922203765551737. AIDS Res Hum Retroviruses. 2003. PMID: 12803997

2

Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.

van Rij RP, Visser JA, van Praag RM, Rientsma R, Prins JM, Lange JM, Schuitemaker H. van Rij RP, et al. Among authors: van praag rm. J Virol. 2002 Mar;76(6):3054-8. doi: 10.1128/jvi.76.6.3054-3058.2002. J Virol. 2002. PMID: 11861873 Free PMC article.

3

Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants.

Kwa D, van Rij RP, Boeser-Nunnink B, Vingerhoed J, Schuitemaker H. Kwa D, et al. Among authors: van rij rp. AIDS. 2003 May 2;17(7):981-5. doi: 10.1097/00002030-200305020-00006. AIDS. 2003. PMID: 12700447

4

Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination.

van Rij RP, Worobey M, Visser JA, Schuitemaker H. van Rij RP, et al. Virology. 2003 Sep 15;314(1):451-9. doi: 10.1016/s0042-6822(03)00454-9. Virology. 2003. PMID: 14517097 Free article.

5

Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen.

van Rij RP, van Praag RM, Prins JM, Rientsma R, Jurriaans S, Lange JM, Schuitemaker H. van Rij RP, et al. Among authors: van praag rm. Antivir Ther. 2002 Mar;7(1):37-41. Antivir Ther. 2002. PMID: 12008786

6

Cell turnover and cell tropism in HIV-1 infection.

Davenport MP, Zaunders JJ, Hazenberg MD, Schuitemaker H, van Rij RP. Davenport MP, et al. Among authors: van rij rp. Trends Microbiol. 2002 Jun;10(6):275-8. doi: 10.1016/s0966-842x(02)02370-3. Trends Microbiol. 2002. PMID: 12088663

7

CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.

Wit FW, van Rij RP, Weverling GJ, Lange JM, Schuitemaker H. Wit FW, et al. Among authors: van rij rp. J Infect Dis. 2002 Dec 15;186(12):1726-32. doi: 10.1086/345677. Epub 2002 Nov 22. J Infect Dis. 2002. PMID: 12447757

8

Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.

Sankatsing SU, van Praag RM, van Rij RP, Rientsma R, Jurriaans S, Lange JM, Prins JM, Schuitemaker H. Sankatsing SU, et al. Among authors: van rij rp, van praag rm. Antivir Ther. 2003 Apr;8(2):137-42. Antivir Ther. 2003. PMID: 12741626

9

Host genetic factors in the clinical course of HIV-1 infection: chemokines and chemokine receptors.

van Rij RP, Schuitemaker H. van Rij RP, et al. Community Genet. 2002;5(2):88-101. doi: 10.1159/000065169. Community Genet. 2002. PMID: 12811024

10

In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists.

Stalmeijer EH, Van Rij RP, Boeser-Nunnink B, Visser JA, Naarding MA, Schols D, Schuitemaker H. Stalmeijer EH, et al. Among authors: van rij rp. J Virol. 2004 Mar;78(6):2722-8. doi: 10.1128/jvi.78.6.2722-2728.2004. J Virol. 2004. PMID: 14990692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters